Overview

Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
To compare the relative vasoconstrictive effects of two topical clobetasol propionate 0.05% lotions in asymptomatic subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Actavis Inc.
Treatments:
Clobetasol